Date(s) - 14 Mar 2019 until 15 Mar 2019
7:30 AM - 6:00 PM
Crowne Plaza Cabana Palo Alto
Have you ever left a conference and realized that you forgot to ask the question you came to get answered? Ever wonder what the FDA’s criteria may be when reviewing your PMA/510(k) submission?
Join us at MDMA’s FDA Forum on March 14-15, 2019 in Palo Alto, CA to get your questions answered.
|When:||March 14-15, 2019|
|Where:||Crowne Plaza Cabana Hotel
4250 El Camino Real
Palo Alto, California
MDMA’s 2019 FDA Forum continues to grow as THE conference to engage with leading policy makers and experts. Be sure not to miss out hearing from FDA officials on how to get your technologies into the marketplace.
Confirmed FDA Speakers Include:
- William Maisel, Deputy Center Director for Science & Chief Scientist, CDRH, FDA
- Bakul Patel, Associate Director for Digital Health, Office of the Center Director, CDRH, FDA
- Marjorie Shulman, Chief of Premarket Notification (510(k)) Section, Office of Device Evaluation, CDRH, FDA
This is a RARE opportunity to share YOUR concerns and ask YOUR questions from some of the FDA’s top officials.
MDMA Members – $595
AZBio Member – $795 (use code “STATE”) AZBio Membership required
Non-Members – $895
For more information and to register, CLICK HERE